Although EBUS-TBNA needles have been widely used in clinical practice, in response to increasingly complex diagnostic and therapeutic requirements (such as drug resistance gene testing and early cancer screening), there is still room for improvement in the current design. This article looks forward to the technical directions of the next-generation EBUS-TBNA needles, including rotatable needle tips, embedded sensors, 3D printing for personalized customization, and AI-assisted navigation.

1. Rotatable Needle Tip: Breaking Through Anatomical Limitations

Currently, the EBUS-TBNA needle is designed for direct rigidity and can only advance along the axis of the bronchoscope. It is often difficult to reach lymph nodes located behind blood vessels or in awkward angles. Drawing inspiration from the deflectable catheters used in cardiovascular interventional procedures, researchers are developing needle tips with a pull wire structure - the needle tip can be bent by 0° to 90° through the handle knob, and in combination with real-time ultrasound images, it enables precise puncture "aiming where to hit." Preliminary animal experiments have shown that the deflectable needle can successfully sample 3R and 8 station lymph nodes that traditional straight needles cannot reach, with a success rate increase of 30%.

II. Embedded Sensors: Integration from Sampling to Diagnosis

In the future, EBUS-TBNA needles may incorporate miniature sensors, which can provide tissue information at the moment of puncture. For instance, an impedance sensor at the needle tip can provide real-time feedback based on the different conductivity differences of various tissues (normal lymph nodes vs. metastatic cancer); a near-infrared spectroscopy probe can detect hemoglobin concentration and oxygen saturation, assisting in differentiating inflammatory swelling from malignant infiltration. Further, embedding a micro-electrode array in the needle body enables electrochemical detection (such as telomerase activity) while obtaining cells, achieving "on-the-spot diagnosis." These functions will shorten the waiting time for ROSE and even replace some of the pathological section requirements.

III. 3D Printed Customized Needles

There are individual differences in the bronchial tree anatomy of each patient, and standardized needles may not be the best choice. By using preoperative CT three-dimensional reconstruction, the selective laser melting (SLM) technology can be employed to print EBUS-TBNA needles that perfectly fit the curvature of the patient's airway. The needle body can be designed with a gradually varying wall thickness - the proximal part is harder to transmit the thrust, and the distal part is softer to accommodate the curvature. In terms of materials, cobalt-chromium alloy or pure titanium powder can replace traditional tubes to achieve better biocompatibility and MRI compatibility. Although the current cost is high, with the improvement in the efficiency of metal 3D printing, personalized customization is expected to enter clinical practice within the next 5-10 years.

IV. AI-assisted Navigation and Automated Puncture

By integrating computer vision and deep learning algorithms, the future EBUS system will be able to automatically identify the boundaries of lymph nodes, the positions of blood vessels, and the optimal puncture paths in ultrasound images. The robotic EBUS-TBNA needle, controlled by the mechanical arm, can autonomously advance along the preset trajectory and stop precisely at the target point under tactile feedback. This "robotic needle" not only reduces the deviation caused by the operator's hand tremors but also senses changes in tissue hardness through force sensors, avoiding excessive puncturing. Preliminary clinical trials have shown that the sample sufficiency rate of AI-assisted puncture has increased from 85% to 96%, and the learning curve has been significantly shortened.

V. Multi-functional Integration: Sampling + Treatment + Labeling

The new generation of EBUS-TBNA needles may also have therapeutic functions: after sampling, radioactive particles (close-range radiotherapy), drug-loaded nanoparticles, or immune activators can be injected through the same needle channel to achieve "diagnosis-treatment integration." In addition, the needle tip can carry fluorescent markers or metal clips, providing precise positioning for subsequent surgical procedures or radiotherapy. This multimodal design will significantly reduce the number of operations patients undergo and lower medical costs.

Conclusion

From a simple hollow needle to an intelligent device integrating sensing, navigation, and treatment, the evolution of EBUS-TBNA needles reflects the transformation of interventional medicine from "experience-driven" to "data-driven." Standing at the 2026 juncture, we have reason to believe that in the not-too-distant future, every lung biopsy will become safer, more precise, and more personalized.